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INTRODUCTION
The human and economic impact of atherosclerotic vascular disease
is formidable.

The National Center for Health Statistics estimates

that in 1978 almost 730,000 deaths, 38% of all deaths occurring in the
United States that year, were attributable to atherosclerotic vascular
disease or its direct complications (ischemic heart disease, cerebro¬
vascular thrombosis, and cerebral embolism)^.

The American Heart As¬

sociation estimated the cost of cardiovascular disease in the United
States to be approximately 28.5 billion dollars in 1978^, and it is
recognized that atherosclerosis accounts for more than 60% of all car¬
diovascular disease^.

Yet despite the intense effort and vast amount

of money expended on research related to atherosclerotic disease there
has been frustratingly meager advancement toward the statement of a
comprehensive theoretical framework within which clinical and basic
science questions concerning atherosclerosis may be addressed.

However

in the past decade primarily due to the work of Ross and Glomset and
their colleagues in formulating and developing the response-to-injury
hypothesis^»62,88-91 # progress toward the statement of a synthetic

theory has been made.

Already the response-to-injury hypothesis has

permitted a more logical approach to major questions concerning the
pathogenesis and progression of atherosclerosis such as the role of
various risk factors, the natural history of vascular lesions, the
origin and fate of incorporated lipids, the role of thrombosis in the
disease process, the significance of the vascular smooth muscle cell,
and the most promising modalities of prevention and treatment.
This study presents an overview of the development of the response
to-injury hypothesis, offers an up-to-date formulation of the patho-
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physiological mechanisms postulated by this theory, and presents data
collected during the course of my thesis research relevant to questions
posed by this theory.

.
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A MODERN THEORY OF THE PATHOGENESIS OF ATHEROSCLEROSIS
A.

Background
All modern theories of the pathogenesis of atherosclerosis find

their origins in the nineteenth century works of von Rokitansky and
Virchow.

In 1852 von Rokitansky proposed that:

"The [a theroscl erotic ] deposit cannot be regarded as
a product (exudation) of an inflammation of the arteries...
The deposit is an endogenous product derived from the blood
and for the most part from fibrin of the arterial blood."86
He postulated that through "metamorphosis" and degeneration these
deposits evolve into advanced atherosclerotic plaques.

In contrast

Virchow viewed atheroma as the result of processes intrinsic to the
vessel wall 10^.

He claimed that irritation of the vascular endothelium

results in a breakdown of the endothelial barrier, allowing infiltration
of plasma constituents into the vessel wall.

These insudated substances

invoke a proliferative reaction of intimal connective tissue cells;
reactive fibrosis in the overlying endothelium manifests itself as a
fibrous cap covering the lesion.

Mallory's demonstration of fibrin-like

material in atherosclerotic lesions^ and Clarke et. al.'s study dis¬
playing a spectrum of lesions ranging from simple mural thrombi to endo¬
thelial ized clot-containing fibrous plaques^ gave further credence to
the significance of thrombosis in the development of atherosclerosis.
However, it wasn't until the 1940's that Duguid refocused attention on
the thrombotic mechanisms proposed by von Rokitansky.

Invoking hemo¬

dynamic arguments he refuted Virchow's then popular view of atheroma
as arising from fibrous overgrowth of degenerative fatty medial lesions^
and cited his own work which demonstrated endothelia 1ization of mural
thrombi and their subsequent organization into intimal plaques^ >25 as

.
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evidence for the crucial role of thrombosis in the genesis of atherosclerosis26’27.

Investigations over the next twenty years49’66, es¬

pecially those looking at the role of fibrin deposition in the develop¬
ment of lesions47,79, intimal thrombosis39,53*'76,39, and a thromboembolic
rabbit model of atheroscl erosi s42 reinforced the importance of thrombotic
mechanisms in the inception and progression of atherosclerotic plaques.
Concurrently, French emphasized the importance of endothelial structure
and response29.

Meanwhile Virchow's view of a proliferative medial

response to intimal irritation was reawakened through studies39,3^>82-85,95
demonstrating that endothelial injury or loss results in the growth of
fibrous intimal plaques characterized by the proliteration of smooth
muscle cells.

These lesions are similar to the focal fibromuscular lesions

seen in human atherosclerosis39’49’63.

However, none of these experimental

lesions evidenced the accumulation or incorporation of lipid, except in
the presence of hypercholesterolemia94.

Renewed interest in the smooth

muscle cell response to endothelial injury developed with the recognition
that delayed .re-endothel ial ization^ 9 or repeated endothelial injury64*66
could lead to the development of lipid containing lesions in normolipemic
animals.

These findings stimulated further investigation which showed

that endothelial injury is not merely an experimentally induced phenomenon
but that it is an ongoing event in both animals9»12>53,80,102 and man46,53s
and the sites where such injury is most often seen correspond to common
loci of atherosclerotic disease.
In 1973 Ross and Glomset reviewed the role of the smooth muscle cell
in atherosclerosis, emphasizing that focal intimal accumulation of these
cells is fundamental to the entire process of atherogenesis".

Citing

much of the evidence noted above, they highlighted the association of

.
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endothelial injury with smooth muscle cell proliferation and the
development of atherosclerosis.

To explain this association they pos¬

tulated that "the intact arterial endothelium normally acts as a barrier
to some substance or substances present in plasma which upon exposure
to vascular smooth muscle promote cell pro! iferation".

They made no

mention of a possible relationship of thrombotic processes to smooth
muscle cell proliferation.

It was not until the following year, with

the identification of a platelet dependent serum factor mitogenic for
smooth muscle cells^ that the response-to-injury hypothesis emerged.
B.

The Response-to-injury Hypothesis^ 4,8 7 - go
Endothelial Injury

(Figure 1)

Ross and Glomset posit intimal injury and the resultant focal
endothelial desquamation as the initial events in atherogenesis.

It

is well established that endothelial injury or denudation resulting from
almost any insul t"*0,14,28,30,45,81 ,82,85,94 will lead to the formation
of fibrous plaques characterized by smooth muscle cell proliferation.
That focal endothelial injury is a common phenomenon in animals and
humans is also well documented^*! 2,46,53,102#

Numerous factors have

been identified as injury causing agents, including the interaction of
hemodynamic forces and formed blood elements with the vessel wall 36>40^
hypertension-^’^ microbiologic agents!! *22,27s immunologic agents^,
blood borne carbon monoxide derived from cigarette smoke and air pol¬
lution^, lipids and chol esterol 3,50,52,78,92, thrombin^, and inappro¬
priate concentrations of normal biologic metabolites^.

Moore has re¬

viewed an extensive body of data and concluded that these factors are
indeed operational in humans^.

He notes the frequent occurrence of

atherosclerotic lesions in human situations where these factors can

6.

be implicated, including:

(1) the association of atherosclerosis with

the risk factors of hypertension, hyperl ipidemia, and cigarette smoking;
(2) atherosclerotic lesions occurring in the walls of autologous vein
grafts exposed to the relative hypertension of arterial pressure;
(3)

the occurrence of atherosclerosis in the arteries of transplanted

organs which are constantly exposed to immunologic damage;

(4) the

high incidence of thromboembolic phenomena in homocystinurics; and
(5) the frequent finding in autopsies performed on neonates who had intra¬
aortic catheters in place of atherosclerotic lesions near the
location of the catheter tip.

The final connection of endothelial injury

to atherosclerosis is made by studies demonstrating that when the endo¬
thelial insult is repetitive or chronic the fibrous plaques will incorporate and retain lipids

*

.

Platelets and Plasma Constituents

(Figures 2 and 3)

Focal endothelial desquamation exposes subendothelia1 cells and
connective tissue to platelets and other blood components.

Ross and

Glomset theorize that this blood-subendothelium interaction is respon¬
sible for the smooth muscle cell response to endothelial injury.

Among

blood constituents, lipoproteins^, insulin^6, and various hormones^9
have been shown to stimulate the migration or proliferation of cells
in vitro, and they may play a similar role in the in vivo stimulation of
smooth muscle cells.

Tissue thromboplastin released by damaged cells

and collagen initiate the clotting cascade to generate thrombin7^.
Although mitogenic for cultured fibroblasts thrombin probably does not
stimulate smooth cells directly.

However thrombin can alter the endo¬

thelial surface so that platelets will adhere to it^ and can stimulate
platelet aggregation and degranulation^.

.
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The most important blood borne mediator of the vascular response
to injury is the platelet.

Platelets adhere to the exposed subendo-

thelial matrix, and their interaction with collagen induces platelet
degranulation^.

Among the substances released by platelet degranulation

is a platelet dependent smooth muscle cell mitogen (PDSMCM) that was
first identified by Ross, et. al.^ in 1 974.

The PDSMCM is a heat

stable basic protein released from platelet alpha-granules during de¬
granulation caused by thrombin, ADP, and other releasing agents.
is mitogenic for cultured smooth muscle cells^’^.

It

The PDSMCM and

perhaps other blood derived substances are presumed by Ross and Glomset
to be the in vivo stimuli for smooth muscle cell migration and prolifera¬
tion subsequent to endothelial injury44>89-91.

The critical in vivo

role of platelets in the vascular response to injury is confirmed
by studies showing the inhibition of fibrous plaque formation by the
induction of thrombocytopenia^’^ or treatment with the anti-platelet
drug dipyridamole^ prior to the causation of endothelial injury.
Progression or Regression?

(Figures 4 and 5)

The response-to-injury hypothesis posits two alternative pathways
for the evolution of an intimal injury.

If the developing plaque is

permitted to re-endothelialize regression of the lesion occurs (Figure
4).

Such regression is observed in many animal models involving a

limited endothelial injury^»14,28,34,82,83,94,95.

However, repeated

or chronic bouts of endothelial injury can lead to continuing smooth
muscle cell proliferation with lipid incorporation* (Figure 5); such

*

One can even envision a scenario whereby the initial injury and
resulting smooth muscle cell proliferation, by creating a raised
plaque protruding into the vessel lumen which is therefore
subject to greater hemodynamic stresses, actually predisposes
to further injury.

.
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a progression is seen in a variety of animal model s33,^>65,67 .

Con¬

tinued proliferation and lipid incorporation may also occur when endo¬
thelial injury synergizes with hyper! ipidemia3’^3,69,77.

The synergistic

effect of hyperl ipidemia may be due to a combination of factors including
a direct stimulatory effect of lipids on smooth muscle cells33,an
injurious effect of lipids on endothelium3,33,33,73,92} lipid induced
platelet hypersensitivity33,37,75 (cigarette smoking also causes plate¬
let hypersensitivity7^), and an irritative effect of insoluble insudated
cholesterol3®.

Lipid accumulating in the lesion may be derived from

either insudated serum lipids or from the smooth muscle cells themselves;
this process is not well understood^.

Regardless, once a lipid con¬

taining plaque is established the well characterized processes of throm¬
bosis and embolization can then act to lead to the development of com¬
plicated atherosclerotic plaques and overt clinical sequelae33,37 ,z*3, 73,/Cr.
Summarizing, the response-to-injury hypothesis postulates endo¬
thelial injury as the initiating factor in atherogenesis, smooth muscle
cell proliteration and migration in response to the PDSMCM and other
serum factors as the initial vascular response, and either regression
of the proliferative lesion or progression in the face of continuing
intimal insult to an atherosclerotic plaque.

The theory accounts

for many experimental and clinical observations concerning athero¬
sclerosis, including the role of endothelial injury, the significance
of smooth muscle cell proliferation, the importance of platelets and
thrombosis, and the association of certain risk factors with clinical
disease patterns.

As Ross and Glomset are quick to note however,

there are gaps in the hypothesis.

It does not in its present form

answer questions regarding the differential incidence and severity

.
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of atheroscl erosis among individuals and population groups.

The

mechanisms of plaque regression, lipid incorporation, and other details
concerning the role of lipids are not specified.

The significance of

the observations of Benditt and Benditt suggesting .that the prolifera¬
tion of smooth muscle cells is monoclonal

is not addressed.

Many

details of the theory also remain to be elucidated, including a further
characterization of the biology and surface characteristics of the
smooth muscle cells, a more complete characterization of the PDSMCM
and other possible mitogens, the role of thrombin and other coagulation
factors in the response to injury, determination of the detailed
mechanism of platelet function at the injury site, and the identifica¬
tion of pharmacological agents that may be used to selectively alter
the response to injury in both research and clinical settings.
C.

This Investigation
The objectives of this study are threefold:

(1) to confirm the

validity of a model recently developed to investigate the vascular
response to endothelial denudation in the rat; (2) to further charac¬
terize observations made with this model; and (3) to use this model
to obtain new data regarding the role of thrombin in the response to
intimal injury.
The use of this model was first reported by Fishman, et. al.28;
they adapted it from a technique employed to study the injury response
of peritoneal mesothel ium93 and have since used the model extensively^-^.
It involves induction of endothelial desquamation and resultant fibrous
plaque formation through creation of a desiccating injury in the rat
carotid artery.

This model was selected for use in this investigation

for several reasons:

(1) as a potentially valuable technique for

.
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the study of myointimal response to vascular injury it warrant fur¬
ther characterization; (2) the endothelial denudation produced is com¬
plete and occurs in a well defined segment of artery; (3) in contrast
to other techniques used to create intimal injury^’^’3^ 31 ,46,64,65 ,
81 -85,94,95,97 there is no metabolic or mechanical insul t33

’^4 to

the media; the injury is purely endothelial; (4) the rat is a well
characterized and inexpensive experimental model; and (5) pharmacologic
intervention in rats is relatively simple.
The

effect of aspirin on the vascular response to injury was in¬

vestigated because of its well known effects on platelets'll and because
of the attention it has received as a possible treatment and/or pro¬
phylaxis for clinical cardiovascular disease'73.

This aspect of the

study repeats investigations made elsewhere3’!3.
Interest in,the role of thrombin in the myointimal response to
injury suggested that the effect of an anti-thrombin agent on the
model be studied.

Heparin has previously been shown to blunt the pro¬

liferative response to injury and it was speculated that this effect
may be due to heparin inhibition of thrombin formation^.

However, the

pharmacological activities of heparin are complex and varied.

To more

clearly elucidate the role of thrombin in the injury response the
effect of warfarin, a drug whose effects are limited solely to its
inhibition of synthesis of the vitamin K dependent clotting factors
(including prothrombin)33, was investigated.

.
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METHODS
Fifty-eight male Sprague-Dawley rats, each weighing 175 to 250
grams, were obtained from Camm Research Institute (Wayne, New Jersey).
All rats were allowed free access to Purina Rodent Laboratory Chow
5001 (Ralston Purina Company, St. Louis, Missouri) and water at all
times.

Assignments to experimental groups were made randomly.

Twenty

rats were assigned to the control group, fourteen to the aspirin group,
and twenty-four to the warfarin group.
Operation
All operations were carried out under ether anesthesia and involved
the creation of a desiccating injury to the left common carotid artery
endothelium according to the method of Fishman, et. al.^.

Briefly

(see Appendix for a detailed 'op-note'), the procedure involved exi

posure of a 2.5 - 3.5 cm. unbranched segment of left common carotid
artery through a midline cervical incision.

Two 4-0 silk ligatures

were tied tightly around the artery approximately 2 cm. apart.

A

30-gauge needle attached via a connecting tube and three-way stopcock
to a syringe containing normal saline and a syringe containing 60 ml.
of room air was then inserted into the lumen of the isolated arterial
segment just distal to the proximal ligature and passed along the lumen,
carefully avoiding contact with the vessel wall.

The needle was ad¬

vanced to a point just proximal to the distal ligature where it was
allowed to penetrate the full thickness of the vessel wall.

It was

then withdrawn back through the lumen until only the tip remained
intraluminal and used to rinse the isolated segment with approximately
0.5 ml. of saline.

Next the stopcock valve was switched and the 60 ml.

.
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of air was streamed gently through the lumen at a rate of 30 ml. per
minute to produce the desiccating endothelial injury.

The lumen was

then refilled with normal saline and the ligatures removed.

Hemostasis

was achieved with gentle pressure applied to the needle holes with
dry or saline moistened gauze sponges; hemostasis was generally at¬
tained in less than three minutes in the control and aspirin treated
rats but often required 7-10 minutes in the warfarin treated rats.

The

skin incision was closed with a single layer of interrupted 4-0 silk
sutures.
Carotid artery specimens for histological examination were obtained
via re-operation through the original incision under ether anesthesia.
The left common carotid artery was again isolated, 4-0 silk ligatures
placed proximally and distally, and the isolated (previously desiccated)
segment resected using a small dissecting scissors and small blunt
forceps.

The sample was immediately rinsed in normal saline and placed

in formalin.

With the rat still alive a 2-3 ml. blood sample was then

obtained via cardiac puncture with a 23-gauge needle for clotting time
determination.
Pharmacological Protocol
Control group rats received no pre-operative or post-operative
treatment.

Two rats were sacrificed without undergoing the desiccation

procedure (Day 0) and two each were sacrificed on the first, third,
fifth, seventh, tenth, twenty-first, and twenty-eighth post-operative
days.

Three control rats were sacrificed on the fourteenth post-operative

day. (Tabl e 1)
The aspirin treated rats received 160 mg. per kg. of powdered
aspirin (McKesson) suspended in glycerin U.S.P. to,a concentration of

.
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50 mg. per ml.

The aspirin suspension was administered via gavage

through a 16-gauge dosing needle 24 hours pre-operatively, immediately
pre-operatively, and then each morning post-operatively until sacrifice.
Three rats were sacrificed on each of the post-operative days 7, 14,
21 and 28. (Table 1)
The warfarin group rats received 0.1 mg. per kg. of warfarin
(Endo) dissolved in tap water to a concentration of 0.05 mg. per ml.
and administered via gavage through a 16-gauge dosing needle.

The

rats were dosed 12 hours pre-operatively, immediately pre-operatively,
36 hours post-operatively, and then each morning until sacrifice.

Two

rats were sacrificed on the seventh post-operative day, and three each
on the fourteenth and twenty-eighth post-operative days. (Table 1)
Clotting Times
Clotting times were determined from 1 ml. samples of whole blood
according to the method of Lee and White^ to the nearest half-minute.
Control samples were obtained from age and weight matched male SpragueDawley rats attained from Camm Research Institute.
Microscopy
Tissue specimens for light microscopy were fixed in formalin
for at least 48 hours, embedded in paraffin, and sectioned.

Sections

were obtained from two to four longitudinally arrayed locations along
the injured segment of artery.

Sections were stained with hematoxylin

and eosin or according to the Elastin-Van Giemsa method.
Intima:media (I/M) ratios were determined by recording for each
section of each specimen the maximal ratio of intimal thickness
(distance from the luminal surface to the internal elastic lamina)
to medial thickness (distance from the internal to the most external

.
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elastic lamina) as measured with an optical graticule, and averaging
these ratios for the sections to arrive at an average I/M ratio for
each particular specimen.

For each sample day a weighted average of

these specimen averages ± S.E.M. was calculated.
S.E.M. cited in this text are x 100.)

(All I/M ratios ±

Sections were scored only if

there was no evidence of luminal or mural thrombosis, the boundaries
of the intima and media were clearly demarcated, and the internal
elastic lamina was intact.

Control and experimental group means were

compared using Student's t-test and hyperplasia growth rates were com¬
pared via linear regression analysis.

.
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RESULTS
Of the 20 control group rats one developed thrombosis of its
left common carotid artery and was discarded.
gained weight and thrived.

All control group rats

One of the 14 aspirin group rats died

for no apparent reason on the third post-operative day and one developed
thrombosis of its left common carotid artery; all others gained weight,
thrived, and completed the study.

Sixteen of the 24 rats in the war¬

farin group died in the period two to nine days post-operatively, ap¬
parently secondary to bleeding diatheses.

Of the eight animals surviving

to completion of the study four evidenced some weight loss and four
demonstrated weight gain and thrived.
Clotting Times
The clotting times of the control rats and the aspirin treated rats
did not differ significantly (Table 2).

The warfarin dosage used in

this study was sufficient to significantly prolong the clotting time
of the warfarin treated rats in comparison to those of both the control
group (2.8 ± 0.5 min. vs. 1.3 ± 0.2 min.; p < 0.05) and the aspirin
group (2.8 ± 0.5 min. vs. 1.5 ± 0.1 min.; p < 0.05) (Table 2).
Histology
Control Group

-

Fishman, et. al.^®.

The observations confirmed those reported by
Pre-operatively (Photograph 1) there is a mono-

layer of delicate endothelial cells with elongated nuclei oriented
parallel to the vessel wall overlying a densely populated dormant
appearing media.

At Day 1 post-operatively (Photograph 2) the endo¬

thelium is completely denuded exposing the internal elastic lamina.
The innermost layers of the media evidence some edema.

At Days 3 and

.

16

5 the medial edema has increased to encompass the full thickness of
the media giving it a vacuolated appearance in both the hematoxylin
and eosin and the Elastin-Van Giesma slides.
are seen.

Occasional medial mitoses

There are no endothelial cells visible in Day 3 slides but

by Day 5 endothelial regeneration is evidenced by the appearance of
an occasional randomly oriented endothelial cell with a swollen nucleus.
Occasional disruptions in the internal elastic lamina are noted, probably
secondary to needle trauma.
Day 7 marks the onset of myointimal proliferation.

Layers of

swollen endothelium two to four cell layers thick now cover many portions
of the formerly exposed internal elastic lamina.

In some areas pro¬

liferating myointimal cells insinuate themselves between the endothelium
and the internal elastic lamina.
still observed in the media.

Medial edema persists and mitoses are

Over the following fourteen days (Photo¬

graphs 3-5) myointimal and endothelial proliferation continue, peaking
sometime between Days 10 and 21.

In many specimens myointimal prolifera¬

tion is the predominant feature, occasionally creating plaques 20 to 30
cells layers thick coated by swollen endothelial cells.

This prolifera¬

tion is not uniform in transverse sections of vessels, leaving some
areas untouched (Photograph 8), but it is regular along the length of
the vessel.

Elastin-Van Giesma stained slides show the plaques to be

virtually overrun with elastin fibers.

During this period the medial

edema begins to resolve and mitoses become infrequent.

By Day 28

(Photograph 6) the hyperplastic myointima is beginning to recede re¬
sulting in a decrease in the average I/M ratio..

Most of the medial

edema has resolved.
At no time during this process is there evidence of medial in-

.
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filtration or adherence to the denuded internal elastic lamina by
polymorphonuclear leukocytes or other inflammatory cells.

Myointimal

hyperplasia is often most pronounced where the internal elastic lamina
is interrupted, but these sites were not used in the determination of
I/M ratios.
Aspirin Group
et. al.l^.

-

The observations confirm those of Clowes,

They differed from the observations made on the control

specimens in only two respects:

1) the maximal myointimal response

is not seen until Day 21 (Photographs 7-9), somewhat later than in
the control group; and 2) in three of the aspirin treated rats (one
sacrificed on Day 21 and two on Day 28) very localized areas of strik¬
ing myointimal proliteration occurs giving the appearance of intra¬
luminal polyps (Photographs 10 and 11).

These "polyps" are endothelial

coated outgrowths of myointima, occasionally growing in whorled patterns,
resting on intact internal elastic laminae.

The myointimal cells are

benign in appearance.
Warfarin' Group

-

Throughout the observation period the changes

in the media of warfarin treated rats parallel those seen in control
group rats; edema is evident but no inflammatory infiltrate is noted.
However, differences in endothelial regeneration and myointimal pro¬
liferation are noted.

Regenerating endothelium in the warfarin group

rats resembled normal endothelium, for the most part lacking the swelling
and disorientation seen in the control and aspirin groups.

Furthermore,

although the peak I/M ratio in the warfarin treated rats is no different
from that seen in the control group (Photographs 12 and 13), the hyper¬
plastic myointima resolves more quickly in the warfarin treated group
(Photographs 14 and 15), resulting in a significantly lower I/M ratio

.
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in Day 28 warfarin group rats than in Day 28 control rats (16.2 ± 2.2
vs. 26.0 ± 3.3 respectively, d < 0.05).
Intima/Media Ratios
The I/M ratios observed are summarized in Table 3.

Comparisons

of the control group data with the aspirin group and warfarin group
data are made in Graphs 1 and 2 respectively.

The hyperplasia in the

control group is seen to peak on Day 10 at an I/M value of 77.8 ± 21.0.
The aspirin treated group did not achieve its peak I/M value until
Day 21, when it was 130.2 ± 50.5.

Maximum hyperplasia was observed

in the warfarin group on Day 14 with an I/M ratio of 44.5 ± 26.8.
These data confirm the histologic impression of the occurrence of
significant hyperplasia in the control and aspirin groups.

At all times

beyond Day 6 the I/M ratios seen in control and aspirin group rats
differ significantly from that seen in unoperated controls (p < 0.05;
Table 4).

No significant difference can be demonstrated between the

I/M ratio observed in unoperated controls and the warfarin group at
Days 7 and 14, although a statistically significant difference is noted
at Day 28 (16.2 ± 2.2 vs. 8.7 ± 1 .5; p < 0.05; Table 4).
These findings also confirm the observations of Clowes, et. al.

18

that aspirin does not affect the rat carotid artery myointimal response
to desiccating endothelial injury.

There are no significant differences

in the I/M ratios at corresponding times between the control and aspirin
groups (Table 3, Graph 1).

Linear regression analysis reveals no sig¬

nificant difference in the rate of increase of the I/M ratios in the
control and aspirin groups.
There is no significant difference between the I/M ratios deter¬
mined in the control and warfarin groups at Days 7 and 14 but there is

.
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a statistically significant greater degree of hyperplasia in the control
group than in the warfarin group at Day 28 (26.0 ± 3.3 vs. 16.2 ± 2.2;
p < 0.05; Table 3, Graph 2).

Again linear regression analysis reveals

no significant difference in the rate of growth of'the I/M ratios in the
control and warfarin groups.

.
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DISCUSSION
Under these experimental conditions carotid artery endothelial
denudation leads to myointimal thickening characterized by smooth
muscle cell proliferation and elaboration of connective tissue.

This

finding concurs with those of numerous other investigators who have
studied this response.

The histologic appearance and evolution of the

lesions is also similar to that reported by other groups^’^*»
81 ,82,94,95.

jn particular this study confirms results obtained by
70

Clowes et. al.

using this same experimental model.

The chronology of development of the features observed in this
00

study is quite similar to that previously reported

.

By twenty-four

hours after desiccation endothelial denudation is uniformly complete
and medial edema is apparent.

Day 7 marks the onset of myointimal

hyperplasia by light microscopic criteria and frequent medial smooth
muscle cell mitoses are evident.
served near Day 14.

Peak myointimal thickening is ob¬

Throughout the period of observation, for reasons

not apparent, the myointimal response is noted to be circumferentially
irregular.

In contrast to observations previously reported °* °, in

the current study medial edema persists through Day 28 and the re¬
generating endothelial cells lack the usually well-defined nuclear
orientation seen in undisturbed endothelium.
not deemed conceptually significant.

These differences are

For no apparent reason the

magnitude of the I/M ratios observed in this study in all groups is
less than those reported by Clowes et. al.

*

by a factor of ap¬

proximately ten.
Observations made on the aspirin treated rats also confirm those

.
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made elsewhere^, again with the exceptions of the persistence of
medial edema and the irregular orientation of endothelial cell nuclei.
Additional observations made in the aspirin group in the course of
this study include:

(1) delay of the peak myointimal response until

Day 21, but because of the marked biological variability seen it is
difficult to attribute this to an effect of aspirin; and (2) the for¬
mation of benign polypoid outgrowths of neointima seen only in aspirin
treated rats; their significance is not known.
The warfarin treated rats exhibit several important deviations
from the findings seen in untreated rats.

No statistically significant

difference can be demonstrated between the I/M ratios observed in
Day 7 and Day 14 warfarin group rats and unoperated control group rats,
although there are clear histologic differences; and the magnitude
of myointimal hyperplasia seen at Day 28 in warfarin treated rats is
statistically significantly less than that seen in the control group
rats.

Both of these findings indicate that warfarin has a suppressive

effect on the smooth muscle cell response to endothelial injury.
The absence of an aspirin effect on the myointimal response to
vessel wall injury is in agreement with previous reports on rat^ and
rabbit^ models.

It is understandable in light of current concepts

regarding the mechanisms of platelet interaction with denuded vessel
wall and the pharmacologic actions of aspirin.

As summarized by

Mustard, et. al.^3»74 endothelial injury results in platelet adherence
to damaged endothelium and exposed subendothelial structures.

Sub-

endothelial collagen stimulates platelet granule release and in
conjunction with tissue thromboplastin derived from damaged cells
activates the coagulation cascade.

Generated thrombin, platelet

.
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released ADP, and endoperoxides PGG2 and PGH2 and thromboxane A2
formed via the arachidonate pathway cause additional platelet ad¬
herence, recruitment of blood borne platelets (aggregation), and
platelet granule release.

Platelet adherence to collagen and col¬

lagen stimulated platelet degranulation are independent of the arachi¬
donate pathway^.

Collagen dependent aggregation is in part mediated

via the arachidonate pathway^.

Platelet degranulation results in

the release of the PDSMCM^»91 .
It has been shown that after the initial adherence of a platelet
monolayer to denuded vessel wall little subsequent platelet turnover
or aggregation occur^1 and fibrin formation is minimal^, indicating
that the critical events are the initial events of adherence and de¬
granulation.

This concept receives further support from a study show¬

ing that to inhibit fibrous plaque formation thrombocytopenia must be
induced prior to endothelial injury^.

Aspirin affects thrombus for¬

mation by blocking the formation of PGG2, PGH2, and thromboxane A2,
through the arachidonate pathway^.

Therefore while aspirin inhibits

platelet aggregation it does not affect platelet adherence to subendothelial structures or platelet degranulation.

Thus it has no

effect on the processes felt to be necessary for release of the PDSMCM.
The expectation that a drug which inhibits platelet adherence and de¬
granulation should reduce the extent of fibrous plaque formation is
confirmed by a study looking at the effect of dipyridamole in homocystinemic baboons^.
The effect of warfarin on the vessel response to injury is almost
certainly related to its suppression of the synthesis of the vitamin K
dependent clotting factors (prothrombin, VII, IX, and X), as it is

.
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largely devoid of other pharmacological activity88.

In particular,

its suppressive effect is probably mediated through its inhibition of
thrombin formation.

However, the details of this effect can only be

conjectured as the role of blood coagulation in the response of the
vessel wall to injury is not well defined.
It is known that thrombin stimulates platelet aggregation and
degranulation through mechanisms at least partly independent of ADP
and the arachidonate pathway^.
release of the PDSMCM^.

Thrombin induced degranulation causes

Additionally, exposure of intact endothelium

to thrombin alters it such that it will permit adhesion of platelets

.

Thus, within the framework of the response-to-injury hypothesis, fac¬
tors which inhibit thrombin formation might be expected to blunt the
smooth muscle cell response by:

(1) inhibiting the thrombin mediated

pathway that leads to release of the PDSMCM; and (2) inhibiting thrombin
induced endothelial injury and the resultant platelet adhesion.
In support of the importance of thrombin to the smooth muscle
cell response to injury is evidence showing marked suppression of the
response by heparin^.

However, it is impossible to determine from

that study whether the suppression is a result of the antithrombin
activity of heparin or one of its many other biological actions.
a strong cation heparin may bind the basic PDSMCM^.

As

Heparin inhibits

wound healing in a variety of situations and may somehow alter the
smooth muscle cell response through a similar effect on endothelial
injury^.

The binding of heparin to negatively charged subendothel ia 1

structures88 may alter platelet-subendothelium interactions, although
this is not morphologically apparent"*^.

Heparin may similarly bind to

the negatively charged platelet surface88 and inhibit platelet surface

.
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interactions.

Lipoprotein lipase, a vessel wall associated enzyme that

clears chylomicrons and fatty acids from blood and that decreases plate¬
let adhesiveness is released by heparin and may thus influence both
platelet activity and local lipid effects^.
Because the only pharmacologic action shared by heparin and war¬
farin is inhibition of thrombin formation it is reasonable to speculate
that their similar suppressive effect on the vascular response to intimal injury is mediated by this anti-thrombin activity.

Of course

the possibility that warfarin exerts its effect solely through its
inhibition of the synthesis of clotting factors VII, IX, and X and that
the heparin suppression is independent of its anti-thrombin activity
cannot be excluded at this time.

If indeed both drugs do act through

an anti-thrombin mechanism, this indicates a central role for thrombin
in the response-fo-injury hypothesis.

Thrombin may exert its influence

through some combination of its effects on endothelium and platelet
function.

More speculatively, the demonstration of the mitogenicity of

the PDSMCM for smooth muscle cells was carried out in the presence of
thrombin^ and perhaps the proteolytic action of thrombin is necessary
to activate the PDSMCM or to alter smooth muscle cell surface receptors
so as to make them more receptive to the mitogen.

.
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SUMMARY
This study used a rat model of desiccating carotid artery endo¬
thelial injury to examine the vessel response to endothelial denudation
and to look at the effect of aspirin and warfarin on this response.
While aspirin had no apparent effect warfarin reduced the magnitude
of the myointimal response.

It is conjectured that this is indicative

of an important but as yet undetermined role for thrombin in vascular
response to injury.

This has important implications for the role of

thrombin in the response-to-injury hypothesis of atherogenesis.

■

.
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APPENDIX:

OPERATIVE NOTE

After anesthetization to unresponsiveness in an ether chamber
the rat was placed on a wooden surgical board and secured by its
extremities.

A rolled up 4 x 4 gauze was placed under the animal's

neck to attain cervical extension.

Anesthesia was maintained through¬

out the procedure with an ether soaked gauze sponge placed in a 50 ml.
beaker near the rat's snout; anesthetic depth was regulated by varying
the distance of the beaker from the snout and monitored by frequent
observation of respiratory pattern and responsiveness to intra-operative
stimuli, with special attention to frequently occurring laryngospasm.
With the animal properly positioned the anterior neck was shaved
and a midline incision made with a #11 knife blade from a point just
superior to the hyoid bone to a point approximately 1/2 cm. superior
to the sternal notch.

Using blunt and sharp dissecting techniques

the fascia joining the submaxillary glands across the midline was
divided; the submaxillary glands were freed from underlying attachments
and retracted laterally under the tension of a pair of small hemostats.
Next the sternohyoid muscles were divided longitudinally in the midline
via blunt dissection and retracted with a small self-retaining retractor
to.expose the trachea.

A small curved hemostat and a pair of small

pointed forceps was used to locate the left common carotid artery by
sliding along the left margin of the trachea (Photograph 17).
unbranched 3 cm. segment was freed up.

An

Two 4-0 silk ligatures were

placed around the artery such that they isolated a 2 cm . segment and
were secured tightly with slip knots to allow atraumatic removal
(Photograph 18).

.

27

Next, using a x2 magnifying visor and the proximal ligature to
manipulate the artery, a 30-gauge needle attached to two 50 ml. syringes
with a connecting tube and three-way stopcock (Photograph 19) was inserted
into the proximal portion of the isolated segment,'Carefully passed up
through the lumen, and then allowed to penetrate the full thickness
of the vessel wall just proximal to the distal ligature.

To prevent

tearing the vessel this distal puncture was made while using surround¬
ing muscle tissue to "back" the arterial wall and thus support it.

The

needle was then carefully withdrawn such that only its tip remained
intraluminal (Photograph 20).

The air filled syringe was depressed so

that the 0.5 ml. of normal saline filling the connecting tube rinsed
the lumen and then a gentle stream of air (30 ml. per minute) was
passed through the lumen for two minutes to cause the desiccating injury.
When this was completed the stopcock was switched to permit refilling
of the lumen with normal saline from the saline syringe and the needle
was fully withdrawn.

The distal ligature was removed and hemostasis

achieved with gentle pressure from a combination of moist and dry
gauze sponges, and then the proximal ligature was removed with bleeding
controlled similarly (Photograph 21).
Before closing the neck was rinsed thoroughly with normal saline
and the sternohyoids were reapproximated with a non-absorbable 4-0
silk suture to assist anatomical orientation at the time of specimen
recovery.
graph 22).

The skin was closed with interrupted 4-0 silk sutures (Photo¬
Approximately two thirds of the rats undergoing this pro¬

cedure had a left Horner's Syndrome post-operatively, but otherwise
apparently complete recovery was achieved within 24 hours.

.
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FIGURE 1
Endothelial injury, which may be caused by many dif¬
ferent forms of injury, exposes the sub-endothelium
to platelets and other blood components (89).

FIGURE 2
A monolayer of platelets adheres to the exposed suben¬
dothelium. Collagen in the sub-endothelium stimulates
the platelets to degranulate, releasing a variety of
factors including the platelet dependent smooth muscle
cell mitogen (89).

FIGURE 3
Smooth muscle cells migrate from the media into the intima through fenestrae in the internal elastic lamina
and proliferate in response to platelet factors and
other plasma constituents (89).

IV

FIGURE 4
Regression of the proliferative lesion shown in Figure 3
occurs if the source of endothelial injury disappears,
leaving a slightly thickened intima containing a few
layers of smooth muscle cells (89).

FIGURE 5
Progression of the proliferative lesion shown in Figure 3
occurs if the source of endothelial injury is chronic or
recurrent, resulting in a proliferative lesion of cells
and connective tissue in a pool of lipid. Thrombosis
may cause further development into a complicated athero¬
sclerotic plaque (89).
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I/M RATIO x 100
DAY

CONTROL

0

8.7 ± 1.5
(4)* *

1

0.0 ± 0.0
(3)

3

13.6
(1)

ASPIRIN
160 mq/kq/da.y

WARFARIN
0.1 mq/kq/day

—

—

—

—

—

—

5

12.2 ± 4.4
(4)

7

21.5 ± 1.5
(4)

10

77.8 ± 21.0
(6)

14

21o0 ± 4o6
(8)

33.8 ± 6.3
(12)

21

34.8 ± 3.7
(6)

130.2 ± 50.5
(12)

28

26.0 ± 3.3
(5)

60.0 ± 18.1
(10)

—

17.4 ± 2.3
(5)

11.2 ± 3.2
(2)

—

—

44.5 ± 26.8
• (10)
—

16.2 ± 2.2
(8)

TABLE 3
INTIMA/MEDIA RATIOS:

I/M ratios ± S.E.M. x 100 in injured carotid
arteries at various time points. Day 0 is
the day of operation.* Day 0 control values
are for uninjured vessels.

* - Number of data points in each group is in parentheses.
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PHOTOGRAPH 1: Day 0 (unoperated) control. One endothelial cell
nucleus is visible in the center, lying upon the internal elastic
lamina. (Hematoxylin and Eosin, x 450; Lumen - Upper left)

PHOTOGRAPH 2: Day 1 control. Note the absence of endothelial cell
nuclei. (Hematoxylin and Eosin, x 450; Lumen - Left half)

XI 11

PHOTOGRAPH 3: Day 10 control. Marked myointimal hyperplasia is
apparent. Note the medial edema. (Hematoxylin and Eosin, x 450;
Lumen - Upper center)

PHOTOGRAPH 4: Day 10 control. Note the copious amount of con¬
nective tissue in the neointima. (Elastin-Van Giemsa, x 450;
Lumen - Upper center)

XIV

PHOTOGRAPH 5: Day 21 control. The myointimal hyperplasia per¬
sists, but has lessened. Medial edema is still evident. (Hema¬
toxylin and Eosin, x 450; Lumen - Left third)

PHOTOGRAPH 6: Day 28 control. Only a minimal amount of intimal
thickening is evident. (Hematoxylin and Eosin, x 450; Lumen Upper right)

XV

PHOTOGRAPH 7: Day 21 aspirin. The myointimal hyperplasia is mas¬
sive, nearly occluding the lumen. (Hematoxylin and Eosin, x 100;
Lumen - Upper right)

PHOTOGRAPH 8: Day 21 aspirin. Note the eccentricity of the intimal thickening. (Elastin-Van Giemsa, x 100; Lumen - Upper right)

XVI

PHOTOGRAPH 9: Day 21 aspirin. A close-up view of the myointimal
proliferation seen in Photographs 7 and 8. (Hematoxylin and Eosin,
x 450; Lumen - Upper right

PHOTOGRAPH 10: Day 14 aspirin, A localized pro!iferation of
smooth muscle cells giving the appearance of an intraluminal
polyp. (Hematoxylin and Eosin, x 100; Lumen - Center)

xv i i

PHOTOGRAPH 11: Day 14 aspirin. A close-up view of the 'polyp'
seen in Photograph 10. (Hematoxylin and Eosin, x 450; Lumen Left two-thirds)

PHOTOGRAPH 12: Day 14 warfarin. Intimal thickening is evident
but not especially pronounced. (Hematoxylin and Eosin, x 450;
Lumen - Upper center)

xvi i i

PHOTOGRAPH 13: Day 14 warfarin. Only a minimal amount of intimal
connective tissue is seen. (Elastin-Van Giemsa, x 450; Lumen Upper right)

PHOTOGRAPH 14: Day 28 warfarin. The intima is normal in appear¬
ance, showing no residual hyperplasia. (Hematoxylin and Eosin,
x 450; Lumen - Upper center)
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XIX

PHOTOGRAPH 15: Day 28 warfarin. Note the absence of intimal
connective tissue. (Elastin-Van Giemsa, x 450; Lumen - Left
third)

XX

PHOTOGRAPH 16: The set of instruments and materials used during
the operative procedure.

PHOTOGRAPH 17: Exposed cervical structures. The hemostats are
retracting the submaxillary glands. The self-retaining retractor
is separating the sternohyoid muscles. The tip of the forceps
is on the left common carotid artery. The glistening structure
in the midline is the trachea.

xx i

PHOTOGRAPH 18: The first ligature being threaded underneath
the left common carotid artery. The artery is sitting on top
of the hemostat just left of the trachea.

PHOTOGRAPH 19: The needle-connecting tube-stopcock-syringe
arrangement. The syringe on the left contains normal saline.
The syringe on the right contains room air. The needle is 30-gauge.

xx n

PHOTOGRAPH 20: The desiccation procedure. The needle tip is
in the vessel lumen. The vessel is manipulated via tension on
the proximal (inferior) ligature. The distal ligature is seen
exiting the wound superiorly.

PHOTOGRAPH 21: Hemostasis is acheived with gentle pressure from
a 4 x 4 gauze sponge.

xx i i i

PHOTOGRAPH 22: The finished product. Approximately two-thirds
the rats undergoing the procedure were left with a left Horner's
Syndrome. Otherwise complete recovery was acheived within twentyfour hours post-operatively.
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